Psyence Biomedical (PBM) has released an update.
Psyence Biomedical Ltd., a Canadian corporation, has issued a Senior Secured Convertible Note with a principal amount of $156,250, maturing on January 25, 2027. The note, convertible under specific conditions, restricts trading before 4 months and a day after distribution or the company’s reporting issuer date in Canada. It also outlines terms for conversion price adjustments related to company transactions and securities market performance.
For further insights into PBM stock, check out TipRanks’ Stock Analysis page.
